| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 07/16/2008 | CN100402492C Androgen receptor suppressors in treatment of hirsutism, acne and androgenetic alopecia |
| 07/16/2008 | CN100402095C Aminoalkyl substituted esters and amides of fumaric acid for neutralising malodor |
| 07/15/2008 | US7399878 Pharmaceutical compounds |
| 07/15/2008 | US7399867 1-(2-{4-[2-(4-Methanesulfonyl-phenyl)-6-methoxy-3,4-dihydro-naphthalen-1-yloxy]-phenoxy}-ethyl)-piperidine for therapy of endometriosis and/or uterine leiomyoma/leiomyomata |
| 07/15/2008 | US7399775 β-amyloid protein production/secretion inhibitor |
| 07/15/2008 | US7399773 Intermediates in the synthesis of atorvastatin calcium (Lipitor (reg)), 5-(4-fluorophenyl)-2-isopropyl-1-(4-(morpholinocarbonylmethylcarbonyl)-2-hydroxybutyl)-4-phenyl-3-(N-phenylcarbamoyl)-1H-pyrrole for example |
| 07/15/2008 | CA2479924C Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization |
| 07/15/2008 | CA2390934C Process for producing benzylamine compound |
| 07/15/2008 | CA2279620C 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4) |
| 07/10/2008 | WO2008081477A1 3-aryloxy 3-substituted propanamines |
| 07/10/2008 | WO2008064039A3 Prostaglandin prodrugs as ocular hypotensive agents |
| 07/10/2008 | WO2008015558A3 Beta-3 receptor ligands and their use in therapy |
| 07/10/2008 | WO2008008884A3 Inhibition of beta-amyloid peptide aggregation |
| 07/10/2008 | WO2007140380A3 Tagging reagents and methods for hydroxylated compounds |
| 07/10/2008 | US20080167378 For the 14273 peroxisome proliferator activated receptor; antidiabetic agents, hyperlipidemia, obesity or anorexia; receptor binding assay; drug screening kits |
| 07/10/2008 | US20080167307 Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof |
| 07/10/2008 | US20080167306 Novel Heteroaryl Derivative |
| 07/10/2008 | US20080167301 Novel Hydroxy-6-Heteroarylphenanthridines and Their Use as Pde4 Inhibitors |
| 07/10/2008 | US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases |
| 07/09/2008 | EP1940821A2 Novel vanilloid receptor ligands and their use for producing medicaments |
| 07/09/2008 | EP1940815A1 Salts of modulators of ppar and methods of treating metabolic disorders |
| 07/09/2008 | EP1940814A1 Piperazine derivatives as antimalarial agents |
| 07/09/2008 | EP1940786A1 Biphenyl derivatives and their use in treating hepatitis c |
| 07/09/2008 | EP1940782A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors |
| 07/09/2008 | EP1940778A1 Puleganic amides as insect repellants |
| 07/09/2008 | EP1720825B1 Anthranilic acid derivatives, methods for their preparation and use as dhodh inhibitors |
| 07/09/2008 | EP1673084B1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms |
| 07/09/2008 | EP1465863B1 Potassium channel modulators |
| 07/09/2008 | EP1379496B1 Sulphones which modulate the action of gamma secretase |
| 07/09/2008 | CN101215274A Technique for preparing N-substituted morpholines organic compounds |
| 07/09/2008 | CN101215239A Combined preparation method for ethylene diamine and aminoethylpiperazine |
| 07/09/2008 | CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 07/09/2008 | CN100400487C Glucocorticoid receptor modulators |
| 07/08/2008 | US7396844 3-(4-amidinobenzoylamino)-4-[5-amidino-2-(2-carboxy-2-oxoethyl)phenoxy]butanoic acid; anticoagulant; blood coagulation factor X and thrombin inhibitor; cerebral infarction, thrombosis, embolism, transient ischemic attack (TIA) and subarachnoidal hemorrhage (vasospasm); ischemic heart diseases |
| 07/08/2008 | US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/08/2008 | US7396834 e.g., 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]benzamide; opioid delta rreceptor agonist; analgesic, hypotensive agent; pain, anxiety and functional gastrointestinal disorders, immunomodulatory activities |
| 07/03/2008 | WO2008078762A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure |
| 07/03/2008 | WO2007147222A3 Novel ionic liquids |
| 07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
| 07/03/2008 | US20080161309 Novel Compounds |
| 07/03/2008 | US20080161304 e.g. 1'-(1-Benzothien-2-ylcarbonyl)-3H-spiro[2-benzofuran-1,4'-piperidine]; vasopressin receptor antagonist; antidepressant, anxiolytic agent; dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder |
| 07/03/2008 | US20080161303 Imidazo- and triazolo-pyridine compounds and methods of use thereof |
| 07/03/2008 | US20080161290 Serine hydrolase inhibitors |
| 07/03/2008 | US20080161281 Amino-Substituted Tricyclic Derivatives and Methods of Use |
| 07/03/2008 | US20080161271 e.g. 9-Hydroxy-2-(2-methoxy-ethyl)-1,8-dioxo-1,8-dihydro-2H-pyrid[1,2-a]pyrazi ne-7-carboxylic acid 4-fluoro-banzylamide; Human T cell leukemia virus, Feline and Simian immunodeficiency virus inhibitor; side effects reduction |
| 07/03/2008 | CA2674548A1 Novel n-(2-aminophenyl) benzamide derivative having urea structure |
| 07/03/2008 | CA2664118A1 Protease inhibitors |
| 07/02/2008 | EP1937677A1 Cb-1 modulating compounds and their use |
| 07/02/2008 | EP1937638A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 07/02/2008 | EP1692127B1 Triphenylethylene compounds as selective estrogen receptor modulators |
| 07/02/2008 | EP1633702B1 Protease inhibitors |
| 07/02/2008 | EP1496838A4 Substituted amides |
| 07/02/2008 | EP1214287B1 Amides as inhibitors for pyruvate dehydrogenase |
| 07/02/2008 | CN101212974A 4-fluoro-piperidine T-type calcium channel antagonists |
| 07/02/2008 | CN101212969A Azinone and diazinone V3 inhibitors for depression and stress disorders |
| 07/02/2008 | CN101210000A Ionic liquid with high electrochemical stability and preparing method thereof |
| 07/02/2008 | CN101209976A Substituted tartaric acid derivatives and use thereof for preparing beta-secretase inhibitor |
| 07/02/2008 | CN100398154C Remedies for psychoneurosis |
| 07/01/2008 | US7393849 N-[4-Amidinobenzoyl]-N-[3-phenoxybenzyl]-3-(4-biphenyl)-alanyl-glycyl-amide; anticarcinogenic, antidiabetic, anticholesterol agent, cardiovascular disorders, osteoporosis |
| 06/26/2008 | WO2008076883A2 Triazine derivatives and their therapeutical applications |
| 06/26/2008 | WO2008075353A1 Sulfonamide derivatives with therapeutic indications |
| 06/26/2008 | WO2008075005A1 Quinuclidinol derivatives as muscarinic receptor antagonists |
| 06/26/2008 | WO2008074887A1 Process of producing amorolfine |
| 06/26/2008 | WO2008074788A1 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 06/26/2008 | WO2008074450A2 Non-peptidic renin inhibitors nitroderivatives |
| 06/26/2008 | WO2008002820A3 Substituted benzyl amine compounds |
| 06/26/2008 | WO2007031512A3 Pesticide bi-phenyl-amidine derivatives |
| 06/26/2008 | US20080153892 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 06/26/2008 | US20080153826 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder |
| 06/26/2008 | US20080153823 a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy |
| 06/26/2008 | US20080153817 Treatment for Alzheimer's Disease and Related Conditions |
| 06/26/2008 | US20080153809 Novel amides useful for treating pain |
| 06/26/2008 | US20080153799 Novel Quinoline-Carbaxamides as Jak3 Kinase Modulators |
| 06/26/2008 | CA2695613A1 Sulfonamide derivatives with therapeutic indications |
| 06/26/2008 | CA2673451A1 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 06/26/2008 | CA2672893A1 Triazine derivatives and their therapeutical applications |
| 06/26/2008 | CA2672404A1 Process of producing amorolfine |
| 06/25/2008 | EP1935889A1 Process of producing amorolfine |
| 06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 06/25/2008 | EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues. |
| 06/25/2008 | EP1935874A1 S1p3 receptor antagonist |
| 06/25/2008 | EP1935869A1 Retinoids for the treatment of emphysema |
| 06/25/2008 | EP1935420A1 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors |
| 06/25/2008 | EP1934263A1 Novel quaternary polymers |
| 06/25/2008 | EP1492534B1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 06/25/2008 | CN101208320A N-hydroxyamide derivatives and use thereof |
| 06/25/2008 | CN101208319A Method for producing an amine |
| 06/25/2008 | CN101205218A Substituted cinnamyl piperazine as well as preparation and uses thereof |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/25/2008 | CN100396668C Non-imidazole aryloxypiperidines |
| 06/24/2008 | US7390924 Terphenyl derivatives, preparation thereof, compositions containing same |
| 06/24/2008 | US7390902 N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-2-methoxy-5-iodo-benzamide; high affinity and high selectivity for sigma 2 receptors; Bromine, Iodine, Carbon, Tritium radioisitops; PET and SPECT; breast cancer |
| 06/24/2008 | US7390833 osteoarthritis; compounds inhibit Aggrecanase Activity of a disintegrin and metalloprotease with thrombosondin type I motifs; biaryl sulfonamid derivatives; N-({4'-[2-4-methylisoquinolin-3-yl)ethyl]-1,1 '-biphenyl-4-yl}sulfonyl)-D-valine |
| 06/24/2008 | US7390812 N, N'-disubstituted piperazine compounds and their use as analgesics |
| 06/19/2008 | WO2008073623A2 Soluble epoxide hydrolase inhibitors |
| 06/19/2008 | WO2008071421A1 Nitrate esters of carbonic anhydrase inhibitors |
| 06/19/2008 | WO2008071398A1 Sulfonamides and their use as a medicament |
| 06/19/2008 | US20080146740 Process for the controlled increase in the molecular weight of polyethylenes |
| 06/19/2008 | US20080146642 Propanesulfonic acid amino acid prodrugs that can deliver 3-amino-1-propanesulfonic acid (3APS) by minimizing metabolism associated with that drug, particularly compounds that block or protect amino group of 3APS such that it avoids metabolism by transaminases or monoamine oxidase; Alzheimer's disease |
| 06/19/2008 | US20080146572 N-sulfonylurea apoptosis promoters |